07/31/2014 - 7:17am

McKesson on Thursday reported revenues of $44.1 billion for the first quarter ended June 30, up 37%. 

07/28/2014 - 11:58am

The Food and Drug Administration on Monday expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia who carry a deletion in chromosome 17.

07/25/2014 - 11:25am

The National Association of Specialty Pharmacy  and the Specialty Pharmacy Association of America announced the merger of the two organizations, creating the largest professional and trade association focused on the unique needs in specialty pharmacy. 



07/24/2014 - 11:03am

Onco360, an independent oncology pharmacy and clinical support services company, announced that it has been selected to be part of the highly limited specialty pharmacy network of Zydelig tablets.

07/23/2014 - 12:02pm

The Food and Drug Administration on Wednesday announced approval for Zydelig (idelalisib) to treat patients with chronic lymphocytic leukemia, relapsed follicular B-cell non-Hodgkin lymphoma and relapsed small lymphocytic lymphoma.

07/21/2014 - 3:01pm

Illinois Gov. Pat Quinn signed a bill Monday that opens up medical marijuana to treat symptoms of epilepsy in adults and children.

07/21/2014 - 11:33am

AbbVie has finalized a deal for Dublin-based specialty pharmaceuticals company Shire for $54.7 billion.

07/21/2014 - 10:27am

Commentary published online Monday addresses the controversy surrounding the high costs of new Hepatitis C virus treatments and implications for the growing specialty pharmacy market. 

 

07/18/2014 - 9:35am

The Food and Drug Administration on Thursday announced the approval of Ruconest, a recombinant C1-Esterase inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema.